Obstetric and gynecological anamnesis in postmenopausal women with ovarian tumors

Abstract

Relevance. Etiology, prevention and treatment of ovarian tumors in postmenopausal patients is an actual scientific issue.

Materials and methods. The paper presents the data of obstetric and gynecological anamnesis, obtained in retrospective study of case histories of postmenopausal patients with benign ovarian tumors (n = 120);

The data regarding patients’ basic complaints are given, the period from the moment of addressing for medical aid to the moment of surgical treatment was analyzed.

Results. The study results showed that ovarian tumors were predominantly diagnosed in patients at late menopause (stage +2 по STRAW+10, Stages of Reproductive Aging Workshop). In most patients, chronic inflammatory diseases of the ovaries and uterus neck were detected in anamnesis. It is important to note that for the examined patients, frequent combination of ovarian tumors with endometrial pathology was not typical, hyperplasia cases had mostly benign course, however atypical hyperplasia of the endometrium was verified in 3 patients out of 120. The basic complaints were pains in the lower parts of the abdomen. The time from the moment of addressing for medical aid to the moment of surgery was on average 5–6 months.

Conclusions. Ovarian tumors were predominantly revealed in patients of late postmenopausal age with concomitant gynecological pathology in anamnesis.

Keywords

Ovarian tumors / peculiar features of anamnesis / postmenopausal age

References

[1] Federal State Statistics Service, avai- lable at: https://rosstat.gov.ru/folder/12781 (in Russian).

[2] Федеральная служба государственной статистики, available at: https://rosstat. gov.ru/folder/12781.

[3] Diagnostics and treatment of benign ovarian neoplasms from the perspective of ovarian cancer prevention: clinical guidelines (treatment protocol). Moscow 2018; 52 (in Russian).

[4] Диагностика и лечение доброкачественных новообразований яичников с позиции профилактики рака яичников: клинические рекомендации (протокол лечения). М. 2018; 52.

[5] The Management of Ovarian Cysts in Postmenopausal Women. RGOG (Green-top Guideline No 34) 2016; 32.

[6] Clinical gynecological oncology. Ed. V.P. Kozachenko. Moscow: Binom. Knowledge Laboratory 2016; 250 (in Russian).

[7] Клиническая онкогинекология. Под ред. В.П. Козаченко. М.: Бином. Лаборатория знаний 2016; 250.

[8] Martynov C.A. Surgical tactics in the treatment of tumor-like formations and ovarian tumors: avtoref. dis. ... dr. med. nauk. Moscow; 2015; 35 (in Russian).

[9] Мартынов C.A. Хирургическая тактика при лечении с опухолевидными образованиями и опухолями яичников: автореф. дис. ... д-ра мед. наук. М. 2015; 35.

[10] Reid B.M., Permuth J.B., Sellers T.A. Epidemiology of ovarian cancer: a review. Cancer Biology & Medicine 2017; 14(1): 9–32.

[11] Reid B., Permuth J., Sellers T. Epidemiology of ovarian cancer: a review. Cancer Biology & Medicine 2017; 14 (1): 9–32.

[12] Stewart L.M., Stewart C., Spilsbury K., Cohen P., Jordan S. Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma. Gynecologic Oncology 2020; 156 (3): 611–615.

[13] Rasmussen C., Kjaer S., Albieri V., Bandera E., Doherty J., Høgdall E., Webb P., Jordan S., Rossing M., Wicklund K., Goodman M., Modugno F., Moysich K., Ness R., Edwards R., . Schildkraut J., Berchuck A., Olson S., Kiemeney L., Massuger L.,. Narod S., Phelan C., Anton-Culver H., Ziogas A., Wu A., Pearce C., Harvey A., Jensen A. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology 2017; 185 (1): 8–20.

[14] Rasmussen C., Kjaer S., Albieri V., Bandera E., Doherty J., Høgdall E., Webb P., Jordan S., Rossing M., Wicklund K., Goodman M., Modugno F., Moysich K., Ness R., Edwards R., Schildkraut J., Berchuck A., Olson S., Kiemeney L., Massuger L.,. Narod S., Phelan C., Anton-Culver H., Ziogas A., Wu A., Pearce C., Harvey A., Jensen A. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology 2017; 185 (1): 8–20.

[15] Reid B., Permuth J., Sellers T. Epidemiology of ovarian cancer: a review. Cancer Biology & Medicine 2017; 14 (1): 9–32.

RIGHTS & PERMISSIONS

Kobaidze E.G., Shashurina Y.A.